A prediction model for pathological findings after neoadjuvant chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma based on endoscopic images using deep learning

被引:12
|
作者
Kawahara, Daisuke [1 ]
Murakami, Yuji [1 ]
Tani, Shigeyuki [2 ]
Nagata, Yasushi [1 ,3 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Hlth Sci, Dept Radiat Oncol, Hiroshima, Japan
[2] Hiroshima Univ, Sch Med, Hiroshima, Japan
[3] Hiroshima High Precis Radiotherapy Canc Ctr, Hiroshima, Japan
来源
BRITISH JOURNAL OF RADIOLOGY | 2022年 / 95卷 / 1135期
关键词
CANCER; CT;
D O I
10.1259/bjr.20210934
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: To propose deep-learning (DL)-based predictive model for pathological complete response rate for resectable locally advanced esophageal squamous cell carcinoma (SCC) after neoadjuvant chemoradiotherapy (NCRT) with endoscopic images. Methods and Material: This retrospective study analyzed 98 patients with locally advanced esophagus cancer treated by preoperative chemoradiotherapy followed by surgery from 2004 to 2016. The patient data were split into two sets: 72 patients for the training of models and 26 patients for testing of the model. Patients was classified into two groups with the LC (Group I: responder and Group II: non-responder). The scanned images were converted into joint photographic experts group (JPEG) format and resized to 150 Chi 150 pixels. The input image without imaging filter (w/o filter) and with Laplacian, Sobel, and wavelet imaging filters deep-learning model to predict the pathological CR with a convolution neural network (CNN). The accuracy, sensitivity, and specificity, the area under the curve (AUC) of the receiver operating characteristic were evaluated. Results: The average of accuracy for the cross-validation was 0.64 for w/o filter, 0.69 for Laplacian filter, 0.71 for Sobel filter, and 0.81 for wavelet filter, respectively. The average of sensitivity for the cross-validation was 0.80 for w/o filter, 0.81 for Laplacian filter, 0.67 for Sobel filter, and 0.80 for wavelet filter, respectively. The average of specificity for the cross-validation was 0.37 for w/o filter, 0.55 for Laplacian filter, 0.68 for Sobel filter, and 0.81 for wavelet filter, respectively. From the ROC curve, the average AUC for the cross-validation was 0.58 for w/o filter, 0.67 for Laplacian filter, 0.73 for Sobel filter, and 0.83 for wavelet filter, respectively. Conclusions: The current study proposed the improvement the accuracy of the DL-based prediction model with the imaging filters. With the imaging filters, the accuracy was significantly improved. The model can be supported to assist clinical oncologists to have a more accurate expectations of the treatment outcome. Advances in knowledge: The accuracy of the prediction for the local control after radiotherapy can improve with the input image with the imaging filter for deep learning.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Neoadjuvant versus adjuvant treatment: Which one is better for resectable locally advanced esophageal squamous cell carcinoma?
    Chen, Qixun
    Xu, Yaping
    Zheng, Yuanda
    Yu, Xinmin
    Lin, Qingren
    Jiang, Youhua
    Zhou, Xinming
    Mao, Weimin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial
    Jun Yin
    Jingnan Yuan
    Yunjin Li
    Yong Fang
    Ruoxi Wang
    Heng Jiao
    Han Tang
    Shaoyuan Zhang
    Siyun Lin
    Feng Su
    Jianmin Gu
    Tian Jiang
    Dong Lin
    Zhiliang Huang
    Chaoxiang Du
    Kui Wu
    Lijie Tan
    Qing Zhou
    Nature Medicine, 2023, 29 : 2068 - 2078
  • [43] A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Yang, Yalan
    Xin, Dao
    Wang, Huike
    Guan, Lulu
    Meng, Xiangrui
    Lu, Taiying
    Bai, Xiwen
    Wang, Feng
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 1443 - 1455
  • [44] Neoadjuvant adebrelimab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: A phase 2 trial
    Li, Zhigang
    Yang, Yang
    Liu, Zhichao
    Li, Chunguang
    Su, Yuchen
    Zhang, Hong
    Liu, Jun
    Zhang, Ming
    Dong, Yun
    Han, Yuchen
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 443 - 443
  • [45] Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial
    Yin, Jun
    Yuan, Jingnan
    Li, Yunjin
    Fang, Yong
    Wang, Ruoxi
    Jiao, Heng
    Tang, Han
    Zhang, Shaoyuan
    Lin, Siyun
    Su, Feng
    Gu, Jianmin
    Jiang, Tian
    Lin, Dong
    Huang, Zhiliang
    Du, Chaoxiang
    Wu, Kui
    Tan, Lijie
    Zhou, Qing
    NATURE MEDICINE, 2023, 29 (08) : 2068 - +
  • [46] Deep learning model based on endoscopic images predicting treatment response in locally advanced rectal cancer undergo neoadjuvant chemoradiotherapy: a multicenter study
    Zhang, Junhao
    Liu, Ruiqing
    Wang, Xujian
    Zhang, Shiwei
    Shao, Lizhi
    Liu, Junheng
    Zhao, Jiahui
    Wang, Quan
    Tian, Jie
    Lu, Yun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (07)
  • [47] Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
    Lou, Xiaoying
    Zhou, Niyun
    Feng, Lili
    Li, Zhenhui
    Fang, Yuqi
    Fan, Xinjuan
    Liu, Hailing
    Yao, Jianhua
    Huang, Yan
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 489 - 490
  • [48] Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
    Lou, Xiaoying
    Zhou, Niyun
    Feng, Lili
    Li, Zhenhui
    Fang, Yuqi
    Fan, Xinjuan
    Ling, Yihong
    Liu, Hailing
    Zou, Xuan
    Wang, Jing
    Huang, Junzhou
    Yun, Jingping
    Yao, Jianhua
    Huang, Yan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
    Lou, Xiaoying
    Zhou, Niyun
    Feng, Lili
    Li, Zhenhui
    Fang, Yuqi
    Fan, Xinjuan
    Liu, Hailing
    Yao, Jianhua
    Huang, Yan
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 489 - 490
  • [50] Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
    Lou, Xiaoying
    Zhou, Niyun
    Feng, Lili
    Li, Zhenhui
    Fang, Yuqi
    Fan, Xinjuan
    Liu, Hailing
    Yao, Jianhua
    Huang, Yan
    MODERN PATHOLOGY, 2022, 35 : 489 - 490